Skip to content

    Laxmi Dental

    LAXMIDENTL
    Healthcare·12 Nov 2025
    Management Summary

    Laxmi Dental delivered a robust performance in Q2 FY26, with strong revenue growth of 26.5% YoY and a significant PAT increase of 44.7% YoY. The company achieved a debt-free status and maintained healthy liquidity. However, margins faced headwinds from US tariffs and a product mix shift towards lower-margin scanner sales, alongside competitive pressures in the domestic aligner market.

    Highlights

    5
    • Revenue from operations for Q2 FY26 grew by 26.5% year-on-year, reaching ₹72.3 crores.

    • PAT for Q2 FY26 increased by 44.7% year-on-year to ₹8.5 crores.

    • Scanner sales grew by 94.7% year-on-year in Q2 FY26, exceeding the number of scanners sold during the entire year of FY25.

    • The company paid off the entire amount of debt from its books, achieving a debt-free status.

    • Cash and bank balance, including fixed deposits, stood at ₹93.7 crores.

    Concerns

    3
    • EBITDA margins for Q2 FY26 were impacted by approximately 90 bps due to US tariffs, ESOP expenses, and annual salary increments, standing at 15.3%.

    • Gross profit margin contracted in Q2 FY26, reflecting 14.5% growth, primarily due to a revenue mix driven by higher scanner sales which have a relatively lower margin profile.

    • The domestic Bizdent (aligner) business continues to face competitive pressure in the market.

    What Changed2

    vs Q3 FY26

    Guidance items8 → 7 (-1)Risks discussed6 → 4 (-2)

    Key financials

    Single quarter

    08 metrics
    1. 01Revenue from Operations₹72.3 Cr+26.5%YoY
    2. 02Gross Profit₹49.5 Cr+14.5%YoY
    3. 03EBITDA₹11 Cr+26.3%YoY
    4. 04EBITDA Margin15.3%
    5. 05PAT₹8.5 Cr+44.7%YoY

    Segment breakdown

    Dental Lab Business (excluding scanner performance)
    29.9% YoY Growth
    Domestic Lab Business
    ₹22.5 Cr Revenue23.2% YoY Growth
    International Lab Business
    ₹18.5 Cr Revenue39.2% YoY Growth
    Aligner Solutions
    ₹20 Cr Revenue12.3% YoY Growth
    Vedia (Aligner Raw Material/Machine)
    29.9% YoY Growth
    Scanner Sales
    94.7% YoY Growth
    Kids-E Dental (JV)
    21.4% QoQ Growth
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Liquidity

    Cash ₹93.7 crores

    Includes fixed deposits.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Revenue Growth
    20%-25%
    High
    Profitability
    PAT Margin
    13%-15%
    High
    Profitability
    EBITDA and PAT Margin
    20%
    Medium
    Profitability
    Vedia Margin Potential
    upwards of 30%
    Medium
    Marketing
    Promotional Spend as % of Revenue
    less than 5%
    High
    Kids-E Dental
    CE Certification
    obtained
    High
    Kids-E Dental
    Growth Rate
    25%-30%
    Medium

    Kids-E Dental CE Certification

    Q4 FY26
    CurrentPending
    TargetObtained

    Why it matters

    CE certification is expected to open up 40 countries for Kids-E Dental, enabling a return to historical growth rates of 25-30%.

    So, I feel that based on the feedback that we have had from our regulatory team, Q4 is when we expect to get the CE, which is an important step. CE opens up almost close to 40-countries for us in the world.

    How to verify

    guidance_and_targets[metric='Kids-E Dental Growth']

    Risks & concerns

    4
    RiskSeverity

    Global Economic Uncertainties

    Volatile and uncertain global economic landscape impacting growth trajectory and margin profile.Management acknowledged

    medium

    US Tariffs

    Impacted Q2 FY26 EBITDA margins by approximately 90 bps, affecting profitability of international business.Management acknowledged

    medium

    Competitive Pressure in Domestic Aligner Market (Bizdent)

    Ongoing competitive pressure in the domestic markets for the Bizdent aligner business.Management acknowledged

    medium

    Gross Profit Margin Contraction due to Product Mix

    Higher scanner sales, which have a relatively lower margin profile, led to a contraction in gross profit margin in Q2 FY26.Management acknowledged

    low

    Q&A highlights

    8

    “If the mix remains currently what it is in Q2, then that should be the expectation. But we expect that along with scanner, we will grow the other businesses as well. So, what we foresee is mid-term to long-term, this mix should change and come back to originally where we were in the range of 75% to 80%.”

    Analyst questioned if lower gross margins due to scanner sales are the new normal; management clarified it's a temporary mix effect, aiming for higher margins long-term.

    asked by Tushar Manudhane

    2 min read6 chapters

    Detailed Narrative

    01

    Robust Q2 & H1 FY26 Financial Performance

    Laxmi Dental reported a strong financial performance for Q2 FY26, with revenue from operations growing by 26.5% year-on-year to ₹72.3 crores. For the first half of FY26, revenue stood at ₹137.9 crores, marking an 18.1% year-on-year growth. PAT for Q2 FY26 saw a significant increase of 44.7% year-on-year, reaching ₹8.5 crores, demonstrating robust bottom-line growth despite market challenges🌐.

    02

    Strategic Focus on Digital Dentistry and Scanner Sales

    The company's commitment to advancing digital dentistry is evident in the remarkable 94.7% year-on-year growth in scanner sales during Q2 FY26. This growth allowed the company to exceed the total number of scanners sold in the entire previous fiscal year (FY25). Management highlighted that scanner adoption enhances patient comfort, reduces turnaround time to two minutes, and offers significant OPEX benefits for dentists, aligning with the strategy to increase digital penetration to over 90% of dentists.

    03

    Segmental Growth Across Lab and Aligner Businesses

    The dental lab business, excluding scanner performance, grew by a solid 29.9% year-on-year in Q2 FY26. This was driven by a 23.2% growth in the domestic lab business to ₹22.5 crores and an even faster 39.2% year-on-year growth in the international lab business to ₹18.5 crores. Aligner solutions revenues also rose by 12.3% year-on-year to ₹20 crores, with Vedia (raw material for aligners) growing 29.9% YoY, showcasing broad-based growth across key segments.

    04

    Margin Dynamics and External Headwinds

    Despite strong revenue growth, Q2 FY26 EBITDA margins were impacted, standing at 15.3%. This was primarily due to a 90 bps impact from US tariffs, along with ESOP expenses and annual salary increments. The gross profit margin also saw a contraction, growing 14.5% YoY, mainly attributed to a shift in revenue mix towards lower-margin scanner sales. Management, however, expects the product mix to normalize mid-to-long term, aiming for gross margins to return to the 75-80% range.

    05

    Debt-Free Status and Healthy Liquidity

    A significant achievement for the quarter was the company becoming debt-free, having paid off the entire amount of debt from its books, leading to a decline in finance costs. This strong financial position is further bolstered by a healthy cash and bank balance, including fixed deposits, totaling ₹93.7 crores. Additionally, ₹64 crores of unutilized IPO proceeds are available for future CAPEX, with ₹6 crores already spent in H1 FY26.

    06

    Strategic Outlook and Competitive Positioning

    Laxmi Dental aims for 20-25% revenue growth and 13-15% PAT margin for FY26, with a mid-to-long term target of 20% for EBITDA and PAT margins. The company emphasizes its 35-year legacy, brand trust (Illusion Zirconia), technological integration, and vertical integration strategy as key differentiators against regional competitors. For Kids-E Dental, management anticipates a return to 25-30% growth rates once CE certification is obtained in Q4 FY26, opening up access to 40 countries.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.